Chronic treatment with indacaterol and airway response to salbutamol in stable COPD

Respiratory Medicine

Volumn 107, Issue 6, 2013, Pages 848-853

  Cazzola, Mario ^a,b   Rogliani, Paola ^a   Ruggeri, Paolo ^c   Segreti, Andrea ^a   Proietto, Alfio ^c   Picciolo, Stefano ^c   Matera, Maria Gabriella ^d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

COPD; Formoterol; Indacaterol; Salbutamol; Tolerance

Indexed keywords

FORMOTEROL; INDACATEROL; SALBUTAMOL;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; AGED, 80 AND OVER; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INDANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINOLONES; VITAL CAPACITY;

EID: 84877585975     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.02.008     Document Type: Article

References (24)

1. 2-adrenoceptor agonists in asthma management Respir Med 99 2005 152 170
2. S. Haney, and R.J. Hancox Rapid onset of tolerance to β-agonist bronchodilation Respir Med 99 2005 566 571
3. J.M. Wraight, R.J. Hancox, G.P. Herbison, J.O. Cowan, E.M. Flannery, and D.R. Taylor Bronchodilator tolerance: the impact of increasing bronchoconstriction Eur Respir J 21 2003 810 815
4. S. Haney, and R.J. Hancox Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial Respir Res 6 2005 107
5. N.A. Hanania, N. Ambrosino, P. Calverley, M. Cazzola, C.F. Donner, and B. Make Treatments for COPD Respir Med 99 Suppl. B 2005 S28 S40
6. M. Cazzola, F. Di Perna, P. Noschese, A. Vinciguerra, F. Calderaro, G. Girbino, and M.G. Matera Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD Eur Respir J 11 1998 1337 1341
7. G.E. La Piana, L. Corda, E. Bertella, L.T. Montemurro, L. Pini, and C. Tantucci Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD Int J Chronic Obstruct Pulm Dis 6 2011 399 405
8. S.J. Charlton Agonist efficacy and receptor desensitization: from partial truths to a fuller picture Br J Pharmacol 158 2009 165 168
9. 2-adrenoceptor agonists: a smart choice for asthma? Trends Pharmacol Sci 28 2007 257 262
10. 2 adrenoceptor agonist with a 24-h duration of action J Pharmacol Exp Ther 317 2006 762 770
11. 2-agonist, on isolated human bronchi Eur Respir J 29 2007 575 581
12. J.F. Donohue, C. Fogarty, J. Lötvall, D.A. Mahler, H. Worth, A. Yorgancioglu, A. Iqbal, J. Swales, R. Owen, M. Higgins, and B. Kramer Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium Am J Respir Crit Care Med 182 2010 155 162
13. 2-agonists indacaterol versus twice-daily formoterol in COPD Thorax 65 2010 473 479
14. O. Kornmann, R. Dahl, S. Centanni, A. Dogra, R. Owen, C. Lassen, and B. Kramer Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison Eur Respir J 37 2011 273 279
15. C.K. Billington, O.O. Ojo, R.B. Penn, and S. Ito cAMP regulation of airway smooth muscle function Pulm Pharmacol Ther 26 2013 112 120
16. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists J Biol Chem 272 1997 23871 23879
17. 2-adrenoceptor Br J Pharmacol 123 1998 701 711
18. 2- adrenoceptor responses in human airway cells during prolonged exposure Br J Pharmacol 158 2009 169 179
19. K.A. Berg, and W.P. Clarke Development of functionally selective agonists as novel therapeutic agents Drug Discov Today 3 2006 421 428
20. S.M. Swift, M.R. Schwarb, K.A. Mihlbachler, and S.B. Liggett Pleiotropic β-agonist-promoted receptor conformations and signals independent of intrinsic activity Am J Respir Cell Mol Biol 36 2007 236 243
21. 2-adrenergic receptor phosphorylation and internalization Am J Respir Cell Mol Biol 36 2007 254 261
22. J.F. Donohue, S. Menjoge, and S. Kesten Tolerance to bronchodilating effects of salmeterol in COPD Respir Med 97 2003 1014 1020
23. N.A. Hanania, C. Kalberg, J. Yates, A. Emmett, D. Horstman, and K. Knobil The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD Pulm Pharmacol Ther 18 2005 19 22
24. J.F. Donohue Therapeutic responses in asthma and COPD. Bronchodilators Chest 126 2 Suppl. 2004 125S 137S